In vitro antibiotic synergy against Flavobacterium meningosepticum: Implications for therapeutic options

Clinical Infectious Diseases

Volumn 26, Issue 5, 1998, Pages 1169-1176

  Di Pentima, M Cecilia ^a   Mason Jr , Edward O ^a   Kaplan, Sheldon L ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFOTAXIME; CIPROFLOXACIN; COTRIMOXAZOLE; LINEZOLID; MEROPENEM; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL MENINGITIS; CASE REPORT; CHRYSEOBACTERIUM MENINGOSEPTICUM; DRUG POTENTIATION; FEMALE; GRAM NEGATIVE INFECTION; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; NEWBORN; PRIORITY JOURNAL; SEPSIS;

EID: 0031949551     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/520309     Document Type: Article

References (27)

1. Thong ML, Puthucheary SD, Lee EL. Flavobacterium meningosepticum: an epidemiologic study in newborn nursery. J Clin Pathol 1981;34:429-33.
2. Dooley JR, Nims LJ, Lipp H, Beard A, Delaney LT. Meningitis in infants caused by Flavobacterium meningosepticum. J Trop Pediatr 1980;26:24-30.
3. Tizer K, Cervia J, Dunn A, Stavola J, Noel G. Successful combination vancomycin and rifampin therapy in a newborn with community-acquired Flavobacterium meningosepticum neonatal meningitis. Pediatr Infect Dis J 1995;14:916-7.
4. Stratton CW, Cooksey RC. Susceptibility test: special tests. In: Balows A, Hausler W, Herrmann K, Isenberg H, Shadomy HJ, eds. Manual of clinical microbiology. 5th ed. Washington DC: American Society for Microbiology, 1991:1159-60.
5. Hawley BH, Gump DW. Vancomycin therapy of bacterial meningitis. Am J Dis Child 1973;126:261-4.
6. Hazuka BT, Dajani AS, Talbot K, et al. Two outbreaks of Flavobacterium meningosepticum type E in a neonatal intensive care unit. J Clin Microbiol 1977;6:450-5.
7. Rios I, Klimek J, Maderazo E, Quintiliani R. Flavobacterium meningosepticum meningitis: report of selected aspects. Antimicrob Agents Chemother 1978;14:444-7.
8. Ferlauto JJ, Wells DH. Flavobacterium meningosepticum in the neonatal period. South Med J 1981;74:757-9.
9. Chandrika T, Adler S. A case of neonatal meningitis due to Flavobacterium meningosepticum successfully treated with rifampin. Pediatr Infect Dis J 1982;1:40-41.
10. Kaplan M, Goldberg MD, Tauber Z, Solomon F, Sompolinsky D. Successful treatment of neonatal Flavobacterium meningosepticum infection. Eur J Pediatr 1983;140:338-43.
11. Bruun B, Jensen TE, Lundstrom K, et al. Flavobacterium meningosepticum infection in a neonatal ward. Eur J Clin Microbiol Infect Dis 1989;8:509-14.
12. Abrahamsen TG, Mollnes TE, Vandvik B. Intrathecal immune response in neonatal Flavobacterium meningosepticum meningitis. Biol Neonate 1995;68:153-6.
13. Abrahamsen TG, Finne PH, Lingaas E. Flavobacterium meningosepticum in a neonatal intensive care unit. Acta Paediatr Scand 1989;78:51-5.
14. Ratner H. Flavobacterium meningosepticum. Infect Control 1984;5:237-9.
15. King E. Studies on a group of previously unclassified bacteria associated with meningitis in infants. Am J Clin Pathol 1959;31:241-7.
16. Teres D. ICU-acquired pneumonia due to Flavobacterium meningosepticum. JAMA 1974;228:732.
17. Werthamer S, Weiner M. Subacute bacterial endocarditis due to Flavobacterium meningosepticum. Am J Clin Pathol 1971;57:410-2.
18. Schiff J, Sutter LS, Gourley RD, et al. Flavobacterium infection as a cause of bacterial endocarditis. Ann Intern Med 1961;55:499-506.
19. Olson HW, Fredricksen C, Siboni KE. Flavobacterium meningosepticum in 8 non-fatal cases of postoperative bacteremia. Lancet 1965;1:1294-6.
20. Aber RC, Wennersten C, Moellering RC. Antimicrobial susceptibilities of flavobacteria. Antimicrob Agents Chemother 1978;14:483-7.
21. Chang JY, Hsueh PR, Wu JJ, Ho SW, Hsieh WC, Luh KT. Antimicrobial susceptibility testing of flavobacteria as determined by agar dilution and disk dilution methods. Antimicrob Agents Chemother 1997;41:1301-6.
22. Placzek M, Whitelaw A, Want S, Sahathevan M, Darrel J. Piperacillin in early neonatal infection. Arch Dis Child 1983;58:1006-9.
23. Decazes JM, Meulemans A, Bure A, Laisne MJ, Modai J. Penetration of piperacillin into the cerebrospinal fluid of patients with purulent meningitis. Presse Med 1984;13:261-4.
24. Lin CH, Hunag FY. Clinical observation of neonatal meningitis caused by F. meningosepticum. Acta Pediatrica Sinica 1991;31:171-6.
25. George RM, Cochran CP, Wheeler WE. Epidemic meningitis of the new-born caused by favobacteria. Am J Dis Child 1961;101:296-304.
26. Mustafa MM, Mertsola J, Ramilo O, Sáez-Llorens X, Risser RC, McCracken GH Jr. Increased endotoxin and interleukin-1β concentrations in cerebrospinal fluid of infants with coliform meningitis and ventriculitis associated with intraventricular gentamicin therapy. J Infect Dis 1989;160:891-95.
27. McGee SM, Kaplan SL, Mason EO. Ventricular fluid concentrations of vancomycin after intravenous and intraventricular administration. Pediatr Infect Dis J 1990;9:138-9.